Pub. Date : 2015 Jun
PMID : 26029452
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | CONCLUSIONS: Patients with CP-A or CP-B advanced HCC should be offered sorafenib at 400 mg twice daily with optimal management of AEs in order to improve survival. | Sorafenib | carboxypeptidase A1 | Homo sapiens |